Factors Related to Severity, Hospitalization, and Mortality of COVID-19 Infection among Patients with Autoimmune Diseases
Authors:
- Alvina WidhaniAWAlvina Widhani
- Sukamto KoesnoeSKSukamto Koesnoe
- Suzy MariaSMSuzy Maria
- Annisa Layalia WidjanarkoAWAnnisa Layalia Widjanarko
- Teguh Harjono KarjadiTKTeguh Harjono Karjadi
- Anshari Saifuddin HasibuanAHAnshari Saifuddin Hasibuan
- Evy YunihastutiEYEvy Yunihastuti
- Iris RengganisIRIris Rengganis
- Samsuridjal DjauziSDSamsuridjal Djauzi
Open Access
- 18 April 2023
- journal article
- research article
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 8 (4) , 227
Abstract
Patients with an autoimmune disease could be at higher risk of a poor outcome when contracting COVID-19 infection due to aberrant immune responses and use of immunosuppressant therapies for chronic autoimmune treatment. Here, we conducted a retrospective study to identify the factors related to severity, hospitalization, and mortality among patients with autoimmune diseases. We found 165 cases of patients with pre-existing autoimmune diseases who had contracted COVID-19 between March 2020 and September 2022. Data on demographical characteristics; autoimmune diagnosis and treatment; COVID-19 vaccination status; and time, severity, and outcome of COVID-19 infection were collected. Most of the subjects were female (93.3%) and autoimmune diagnoses included systemic lupus erythematosus (54.5%), Sjogren’s syndrome (33.5%), antiphospholipid syndrome (23%), vasculitis (5.5%), autoimmune thyroid disease (3.6%), rheumatoid arthritis (3.03%), and inflammatory bowel disease (3.03%) among other autoimmune diseases. There were four COVID-19-related deaths in this study. Factors associated with moderate to severe COVID-19 infection in patients with autoimmune diseases included not being vaccinated against COVID-19, taking a steroid of ≥10 mg prednisone-equivalent per day, and having a cardiovascular disease. Taking a steroid of ≥10 mg prednisone-equivalent per day was also associated with hospitalization in the event of COVID-19 infection, while cardiovascular diseases also showed a significant correlation to mortality in patients with autoimmune diseases who had been hospitalized with COVID-19 infection.Keywords
Funding Information
- Adult Immunization Task Force of The Indonesian Society of Internal Medicine
This publication has 40 references indexed in Scilit:
- SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patientsJournal of Autoimmunity, 2020
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registryAnnals of the Rheumatic Diseases, 2020
- Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysisDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen nextMetabolism, 2020
- Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID‐19Clinical and Translational Science, 2020
- Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?Autoimmunity Reviews, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID‐19): A Chinese perspectiveJournal of Medical Virology, 2020
- Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-AnalysisResearch, 2020